Is it time to stop treating dyslipidaemia with fibrates?


AIM To determine whether evidence from randomised clinical trials supports the use of fibrates to reduce non-fatal and fatal cardiovascular events in patients with dyslipidaemia. METHOD Review of randomised clinical trials of fibrates that assess clinical outcomes. RESULT In clinical trials which have which have included over 40,000 patients there was… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.